China Cancer Diagnostics Firm Genetron’s Revenue Gains After IPO

Genetron is one of two precision oncology firms from China to IPO in the U.S. in recent months. The other, Burning Rock Biotech, raised $281 million from a public offering and private placement.
( read original story …)